ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Vernalis, weakened by FDA rejections, accepts ￡33M Ligand bid
fiercebiotech
August 13, 2018Ligand Pharmaceuticals is set to?acquire?Vernalis for the knockdown price of ￡33 million ($42 million). The takeover agreement comes one year after Vernalis was left reeling by a second FDA rejection in quick succession.
Pharma Sources Insight January 2025
